Genetic basis of syndromes associated with congenital heart disease.

Numerous syndromes affecting patients have phenotypes that include congenital heart defects (CHDs). These disorders have fascinated physicians for many years, raising questions about how seemingly disparate aspects of human development can be perturbed together in striking, but consistent, ways. Paralleling the major advances in human genetics during recent decades, we have come to understand that some of these syndromes arise from gross defects in chromosomal number, some from subtler alterations in genomic regions, and still others from point mutations in specific genes. These disorders, largely mendelian in nature, have provided researchers with the wherewithal to discover disease genes underlying CHD. Although some of these medical conditions are relatively rare, their solution has often provided insights that could be applied toward understanding the basis of nonsyndromic CHD. In this review, recent progress toward uncovering the molecular basis of several forms of syndromic CHD is discussed.

[1]  J. Friedman,et al.  del(20p) with manifestations of arteriohepatic dysplasia. , 1986, American journal of medical genetics.

[2]  C. Disteche,et al.  Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. , 1992, American journal of human genetics.

[3]  M. Hadchouel,et al.  Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome. , 1999, Gastroenterology.

[4]  M. Tigges,et al.  A novel 22q11.2 microdeletion in DiGeorge syndrome. , 1999, American journal of human genetics.

[5]  P. Scambler,et al.  Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. , 1999, Human molecular genetics.

[6]  E. Zackai,et al.  Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. , 1993, Journal of medical genetics.

[7]  E. Zackai,et al.  Prevalence of 22 q 1 1 microdeletions in DiGeorge and velocardiofacial syndromes : implications for genetic counselling and prenatal diagnosis , 2022 .

[8]  I. Krantz,et al.  Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families. , 1998, American journal of human genetics.

[9]  R. Kucherlapati,et al.  Mutations in human cause limb and cardiac malformation in Holt-Oram syndrome , 1997, Nature Genetics.

[10]  J. Weber,et al.  Autosomal dominant supravalvular aortic stenosis: localization to chromosome 7. , 1993, Human molecular genetics.

[11]  F. Char Peculiar facies with short philtrum, duck-bill lips, ptosis and low-set ears--a new syndrome? , 1978, Birth defects original article series.

[12]  R. Shprintzen,et al.  A common molecular basis for rearrangement disorders on chromosome 22q11. , 1999, Human molecular genetics.

[13]  C. Morris,et al.  Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients. , 1995, American journal of human genetics.

[14]  M. Gebbia,et al.  Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. , 1999, American journal of medical genetics.

[15]  R. Matalon,et al.  Unbalanced 15;22 translocation in a patient with manifestations of DiGeorge and velocardiofacial syndrome. , 1997, American journal of medical genetics.

[16]  B. Koller,et al.  The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth , 1997, Nature.

[17]  C. Cottrill,et al.  Supravalvular aortic stenosis. Clinical and pathologic observations in six patients. , 1985, Archives of pathology & laboratory medicine.

[18]  B. Morrow,et al.  Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. , 1999, American journal of human genetics.

[19]  J. Denie,et al.  Supravalvular Aortic Stenosis , 1958, Circulation.

[20]  L. Silver,et al.  Expression of the T‐box family genes, Tbx1–Tbx5, during early mouse development , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[21]  P. Scambler,et al.  Molecular cytogenetic characterization of the DiGeorge syndrome region using fluorescence in situ hybridization. , 1993, Genomics.

[22]  H. Kurahashi,et al.  Deletion mapping of 22q11 in CATCH22 syndrome: identification of a second critical region. , 1996, American journal of human genetics.

[23]  R. Newbury-Ecob,et al.  Holt–Oram syndrome is a genetically heterogeneous disease with one locus mapping to human chromosome 12q , 1994, Nature Genetics.

[24]  A. Takao,et al.  [Congenital supravalvular aortic stenosis]. , 1966, Kyobu geka. The Japanese journal of thoracic surgery.

[25]  J. Morrow,et al.  Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Jones,et al.  JAGGED1 expression in human embryos: correlation with the Alagille syndrome phenotype , 2000, Journal of medical genetics.

[27]  E. Zackai,et al.  Jagged1 mutations in patients ascertained with isolated congenital heart defects. , 1999, American journal of medical genetics.

[28]  J. Seidman,et al.  Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Emanuel,et al.  A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. , 1992, American journal of human genetics.

[30]  J. Seidman,et al.  Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. , 1999, Developmental biology.

[31]  R. Newbury-Ecob,et al.  Holt-Oram syndrome: a clinical genetic study. , 1996, Journal of medical genetics.

[32]  A. Ballabio,et al.  Mapping a gene for familial situs abnormalities to human chromosome Xq24-q27.1 , 1993, Nature Genetics.

[33]  H. Kurahashi,et al.  Another critical region for deletion of 22q11: a study of 100 patients. , 1997, American journal of medical genetics.

[34]  M. Pierpont,et al.  Familial occurrence of patent ductus arteriosus. , 1995, American journal of medical genetics.

[35]  M. Leppert,et al.  A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  David I. Wilson,et al.  Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family , 1997, Nature Genetics.

[37]  G. Herman,et al.  The X-linked mouse mutation Bent tail is associated with a deletion of the Zic3 locus. , 2000, Human molecular genetics.

[38]  C. Morris,et al.  Supravalvular aortic stenosis cosegregates with a familial 6; 7 translocation which disrupts the elastin gene. , 1993, American journal of medical genetics.

[39]  M. Polymeropoulos,et al.  Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis , 2000, Nature Genetics.

[40]  C. Basson,et al.  Identification and localization of TBX5 transcription factor during human cardiac morphogenesis , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[41]  J. Belmont,et al.  Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. , 1999, American journal of human genetics.

[42]  M. Yamada,et al.  Mutational analysis of the Jagged 1 gene in Alagille syndrome families. , 1998, Human molecular genetics.

[43]  R. Kucherlapati,et al.  Normal cardiovascular development in mice deficient for 16 genes in 550 kb of the velocardiofacial/DiGeorge syndrome region. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Schlessinger,et al.  X-linked situs abnormalities result from mutations in ZIC3 , 1997, Nature Genetics.

[45]  A. Bradley,et al.  Congenital heart disease in mice deficient for the DiGeorge syndrome region , 1999, Nature.

[46]  C. Morris,et al.  Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. , 1997, Human molecular genetics.

[47]  S. Solomon,et al.  The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome) , 1994, The New England journal of medicine.

[48]  D. Srivastava,et al.  A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. , 1999, Science.

[49]  O. Delattre,et al.  Physical mapping by FISH of the DiGeorge critical region (DGCR): involvement of the region in familial cases. , 1993, American journal of human genetics.

[50]  Colin C. Collins,et al.  Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 , 1997, Nature Genetics.

[51]  R. Kucherlapati,et al.  Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients. , 1997, American journal of human genetics.

[52]  N. Spinner,et al.  The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome. , 1999, Human molecular genetics.

[53]  Paul S. Meltzer,et al.  Mutations in the human Jagged1 gene are responsible for Alagille syndrome , 1997, Nature Genetics.

[54]  M. Hattori,et al.  The DNA sequence of human chromosome 21 , 2000, Nature.

[55]  J. Dumanski,et al.  Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. , 1992, American journal of human genetics.

[56]  L. Shaffer,et al.  A submicroscopic deletion in Xq26 associated with familial situs ambiguus. , 1997, American journal of human genetics.

[57]  I. Dunham,et al.  Molecular definition of the 22q11 deletions in velo-cardio-facial syndrome. , 1995, American journal of human genetics.

[58]  D. G. Chen,et al.  Holt-Oram syndrome. , 1986, Chinese medical journal.

[59]  B. Gelb,et al.  Char syndrome, an inherited disorder with patent ductus arteriosus, maps to chromosome 6p12-p21. , 1999, Circulation.

[60]  K. Mikoshiba,et al.  Xenopus Zic3, a primary regulator both in neural and neural crest development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  B. Gelb,et al.  Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus , 2000, Nature Genetics.

[62]  R. Stevenson,et al.  A new X linked mental retardation (XLMR) syndrome with short stature, small testes, muscle wasting, and tremor localises to Xq24-q25 , 2000, Journal of medical genetics.

[63]  M. Hattori,et al.  The DNA sequence of human chromosome 21 The chromosome 21 mapping and sequencing consortium , 2000 .

[64]  C. Disteche,et al.  Down syndrome phenotypes: the consequences of chromosomal imbalance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Colleen A. Morris,et al.  The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis , 1993, Cell.

[66]  Alexander F. Schier,et al.  Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects , 2000, Nature Genetics.

[67]  B. Franke,et al.  A deletion encompassing Zic3 in bent tail, a mouse model for X-linked neural tube defects. , 2000, Human molecular genetics.

[68]  M. Polymeropoulos,et al.  The gene for the Ellis-van Creveld syndrome is located on chromosome 4p16. , 1996, Genomics.

[69]  M. Vekemans,et al.  JAGGED1 Gene Expression During Human Embryogenesis Elucidates the Wide Phenotypic Spectrum of Alagille Syndrome , 2000, Hepatology.

[70]  M. Oshimura,et al.  Specific impairment of cardiogenesis in mouse ES cells containing a human chromosome 21. , 2000, Biochemical and biophysical research communications.

[71]  M. Horb,et al.  Tbx5 is essential for heart development. , 1999, Development.

[72]  R. Mecham,et al.  Novel arterial pathology in mice and humans hemizygous for elastin. , 1998, The Journal of clinical investigation.